Education
About Us
Working with TipRanks
Follow Us
Avanos Medical (AVNS)
NYSE:AVNS
AVNS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$14.40 - $25.36
Previous CloseN/A
Volume92.13K
Average Volume (3M)498.11K
Market Cap
$692.35M
Enterprise Value$1.23B
Total Cash (Recent Filing)$384.50M
Total Debt (Recent Filing)$247.70M
Price to Earnings (P/E)45.8
Beta1.42
Next Earnings
Apr 30, 2025EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.53
Shares Outstanding46,003,150
10 Day Avg. Volume527,843
30 Day Avg. Volume498,114
Standard Deviation0.10
R-Squared0.24
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)3.00
P/FCF Ratio3.00
Enterprise Value/Market Cap1.78
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.25
Enterprise Value/Ebitda12.76
Forecast
1Y Price Target
$17.00Price Target Upside12.96% Upside
Rating ConsensusHold
Number of Analyst Covering2
---
Avanos Medical News
PremiumCompany Announcements
Avanos Medical’s Earnings Call: Mixed Sentiments and 2025 Outlook
PremiumCompany Announcements
Avanos Medical Reports 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Business TransformationThe ongoing transformation continues to progress positively through the finalized Respiratory Health asset transfer, business efficiency programs, and creation of an AI Solutions portfolio.
Product PerformanceDigestive Health sales at $105.8M continued to outperform estimates, increasing ~12% Y/Y helped by the continued Neomed ENFit conversion tailwind.
Bears Say
Market EnvironmentManagement's initial full-year 2025 guidance was light of Street expectations, calling for flat to slight declines in both revenue and earnings, reflecting a challenging market environment for some of its product categories, currency headwinds, and other macro factors.
Revenue GuidanceThe company lowered its full-year 2024 guidance expectation, with revenue and adjusted EPS forecasted to be lower.
---
Ownership Overview
2.31% Insiders
30.95% Mutual Funds
0.05% Other Institutional Investors
37.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AVNS FAQ
What was Avanos Medical’s price range in the past 12 months?
Avanos Medical lowest stock price was $14.40 and its highest was $25.36 in the past 12 months.
What is Avanos Medical’s market cap?
Avanos Medical’s market cap is $692.35M.
When is Avanos Medical’s upcoming earnings report date?
Avanos Medical’s upcoming earnings report date is Apr 30, 2025 which is in 57 days.
How were Avanos Medical’s earnings last quarter?
Avanos Medical released its earnings results on Feb 26, 2025. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.4 by $0.03.
Is Avanos Medical overvalued?
According to Wall Street analysts Avanos Medical’s price is currently Undervalued.
Does Avanos Medical pay dividends?
Avanos Medical does not currently pay dividends.
What is Avanos Medical’s EPS estimate?
Avanos Medical’s EPS estimate is 0.18.
How many shares outstanding does Avanos Medical have?
Avanos Medical has 46,003,150 shares outstanding.
What happened to Avanos Medical’s price movement after its last earnings report?
Avanos Medical reported an EPS of $0.43 in its last earnings report, beating expectations of $0.4. Following the earnings report the stock price went up 0.386%.
Which hedge fund is a major shareholder of Avanos Medical?
Currently, no hedge funds are holding shares in AVNS
---
Avanos Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$17.00 (12.96% Upside)
$17.00 (12.96% Upside)
Blogger Sentiment
Bullish
AVNS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 19.4K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.51%
12-Months-Change
Fundamentals
Return on Equity
-37.42%
Trailing 12-Months
Asset Growth
-31.80%
Trailing 12-Months
Company Description
Avanos Medical
Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
---
AVNS Company Deck
---
AVNS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment. The company achieved strong performance in its enteral feeding portfolio and improved its financial position significantly. However, these positive outcomes were offset by a substantial non-cash impairment charge and challenges in the pain management and recovery portfolio. Additionally, the outlook for 2025 indicates a pause in margin improvement and flat sales expectations.Read More>---
AVNS Stock 12 Month Forecast
Average Price Target
$17.00
▲(12.96% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Hologic
―
Medtronic
―
Zimmer Biomet Holdings
―
Best Analysts Covering AVNS
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-24.20%
reiterated a buy rating 10 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -24.20% per trade.
---